clinical and microbiological efficacy of arimedadi oil
- Conditions
- Health Condition 1: K051- Chronic gingivitis
- Registration Number
- CTRI/2021/05/033384
- Lead Sponsor
- mme kulsum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Subjects with chronic gingivitis GI score > 0.1and PI score >= 1
2.Subjects with age group of 19 to 64 years.
3.Subjects having minimum of 20 teeth in the oral cavity.
4.Systemically healthy patients.
5.Subjects who give informed consent to participate in the study.
1.Subjects undergoing fixed orthodontic treatment or prosthesis.
2.Subjects who have undergone periodontal surgical or non-surgical treatment 6 months prior to the study.
3.Subjects using any form of adjunctive chemotherapeutic agents.
4.History of systemic antibiotic administration within 3 months prior to the study or any other regular medication.
5.Pregnancy and Lactation
6.Subjects with history of tobacco chewing, alchohol consumption and smoking.
7.History of allergy to chlorhexidine or any other herbal products.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method oTo evaluate the efficacy of Arimedadi oil as an adjuvant to scaling on clinical and microbiological parameters.Timepoint: baseline,14th day and 21st day
- Secondary Outcome Measures
Name Time Method oTo evaluate the efficacy of 0.2% Chlorhexidine gluconate mouthwash as an adjuvant to scaling on clinical and microbiological parameters.Timepoint: baseline,14th day and 21st day;oTo evaluate the efficacy of scaling alone on clinical and microbiological parameters.Timepoint: baseline,14th day and 21st day